Proposed
Bill · 119th Congress · S 4939
Countering CCP Act
Refreshed 27 min ago
Introduced 2026-06-24Topic: health care · technology privacySummary
AI-generated summary, report an errorThis bill would require the Food and Drug Administration, working with the Cybersecurity and Infrastructure Security Agency, to review internet-connected medical devices made by manufacturers headquartered in or owned or controlled by China for cybersecurity issues. Within 180 days, the agency would request information from these manufacturers, including software components and the locations of servers holding patient data. Within 18 months, devices found to pose a cybersecurity risk would be ordered to stop being distributed, and health providers and affected patients would be notified. Devices whose makers do not provide the requested information within 180 days would face the same order, unless a recall would cause a shortage that endangers patients. The agency would also report to Congress within 2 years on the device industry's cyber preparedness and Chinese manufacturers' market share.
Sponsors
- Tom Cotton Republican sponsor
- 1 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-06-24 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | refer |
| 2026-06-24 | Introduced in Senate | introduce |